Semaglutide and atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials

Back

ESC Professional Premium Access

Semaglutide and atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials

Session: Management of comorbidities and outcomes in atrial fibrillation (1)

Topic: Pathophysiology and Mechanisms

Speaker: Doctor G. Costa (Coimbra, PT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Goncalo Costa

Centro hospitalar de Coimbra, Coimbra (Portugal)

0 follower

7 more presentations in this session

Insights into type 2 diabetes mellitus in atrial fibrillation patients: a proteomics approach

Speaker: Miss N. Atzemian (Zurich, CH)

Inflammation and long-term outcomes after first-time direct current cardioversion for atrial fibrillation: a nationwide register study

Speaker: Doctor A. Langhoff (Copenhagen, DK)

Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial aibrillation: a report from 2 prospective observational registries

Speaker: Doctor J. Imberti (Modena, IT)

Risk of embolic events in patients with Chagasic Cardiomyopathy and Atrial Fibrillation despite antithrombotic therapy: is anticoagulation enough?

Speaker: Doctor L. Echeverria (Floridablanca, CO)

Access

Abstract

Slides

Treated obstructive sleep apnoea and incident arrhythmias

Speaker: Doctor H. He (Coventry, GB)

Access the full session

Management of comorbidities and outcomes in atrial fibrillation (1)

Speakers: Doctor G. Costa, Miss N. Atzemian, Doctor A. Langhoff, Doctor J. Imberti, Doctor L. Echeverria...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources